COVID-19: FDA authorizes second booster dose of Pfizer/BioNTech for individuals aged 50 years and older

COVID-19: FDA authorizes second booster dose of Pfizer/BioNTech for individuals aged 50 years and older

FPJ Web DeskUpdated: Tuesday, March 29, 2022, 08:29 PM IST
COVID-19: FDA authorizes second booster dose of Pfizer/BioNTech for individuals aged 50 years and older
COVID-19: FDA authorizes second booster dose of Pfizer/BioNTech for individuals aged 50 years and older | (Photo by AFP)

The FDA has authorized second booster of Pfizer/BioNTech COVID-19 shot for individuals aged 50 years and older.